This in vitro study describes a novel cell culture, transport, and transfer protocol that may be highly suitable for delivering cultured proliferating keratinocytes and melanocytes to large open skin wounds (e.g., burns). We have taken into account previous limitations identified using other keratinocyte transfer techniques, such as regulatory issues, stability of keratinocytes during transport (single cell suspensions undergo terminal differentiation), ease of handling during application, and the degree of epidermal blistering resulting after transplantation (both related to transplanting keratinocyte sheets). Large numbers of proliferating epidermal cells (EC) (keratinocytes and melanocytes) were generated within 10-14 days and seeded onto a threedimensional matrix composed of elastin and collagen types I, III, and V (Matriderm), which enabled easy and stable transport of the EC for up to 24 h under ambient conditions. All culture conditions were in accordance with the regulations set by the Dutch Central Committee on Research Involving Human Subjects (CCMO). As an in vitro model system for clinical in vivo transfer, the EC were then transferred from Matriderm onto human acellular dermis during a period of 3 days. After transfer the EC maintained the ability to regenerate into a fully differentiated epidermis containing melanocytes on the human dermis. Proliferating keratinocytes were located in the basal layer and keratin-10 expression was located in differentiating suprabasal layers similar to that found in human epidermis. No blistering was observed (separation of the epidermis from the basement membrane). Keratin-6 expression was strongly upregulated in the regenerating epidermis similar to normal wound healing. In summary, we show that EC-Matriderm contains viable, metabolically active keratinocytes and melanocytes cultured in a manner that permits easy transportation and contains epidermal cells with the potential to form a pigmented reconstructed epidermis. This in vitro study has produced a robust protocol that is ready for clinical studies in the future.
INTRODUCTION
large wounds, the availability of donor site skin may be a limiting factor. Alternative methods for closing large wounds and in particular for reepithelializing these Optimal closure of large cutaneous wounds such as burns, trauma-induced wounds, and surgical excision wounds have been sought for many years. It is thought that application of cultured epithelial cells in combinawounds is still a major challenge for clinicians. Delayed wound closure increases the risk of infection, dehydration with a dermal matrix may provide a future means of obtaining superior wound healing while at the same tion, and adverse (hypertrophic) scar formation. Therefore, the time taken for wound closure is very important time solving the problem when donor site skin is limited. for the final quality of the wound healing. Transplantation of full or split-thickness (often meshed) autograft is Application of cultured confluent autologous keratinocyte sheets was the first alternative method used to restill the most commonly used method for closing large cutaneous wounds (2) . However, results are often conplace split-thickness autograft, particularly for the treatment of major burns. The method was developed by sidered suboptimal, particularly when expanded meshed autografts are used. Also, when treating particularly Rheinwald and Green in 1975 (22) and the first applica-tion for treating extensive third-degree burns was in (Hyclone, UT, USA). Cells were then co-seeded into tissue culture dishes coated with 0.5 µg/cm 2 human placen-1981 (20) . Whereas at the time this methodology provided a life-saving breakthrough for many patients, a tal collagen IV at a density of 3 × 10 6 cells per 9-cmdiameter culture dish (Sigma-Aldrich, St. Louis, MO, number of major drawbacks have now been realized, making it unacceptable for current medical and ethical USA) and cultured in keratinocyte culture medium at 37°C, 7.5% CO 2 . Keratinocyte culture medium consisted testing committees. These drawbacks include the use of lethally irradiated 3T3 murine fibroblasts in order to sufof Dulbecco's modified Eagle's medium (DMEM)/ Ham's F12 (Lonza, Verviers, Belgium) in a 3:1 ratio ficiently amplify the yield of keratinocytes. Such coculture is accompanied with the risk of viruses, prions, or supplemented with 5% fetalclone III (Hyclone), 1 µmol/ L hydrocortisone (Sigma-Aldrich), 1 µmol/L isoprotereother macromolecules being transmitted from the feeder cells to the human cells during culture (5) . In a previous nol hydrochloride (Sigma-Aldrich), 0.09 µmol/L insulin (Sigma-Aldrich), 2 ng/ml human keratinocyte growth study we solved this problem by culturing keratinocytes on collagen IV, which eliminated the requirement of factor (Sigma-Aldrich), 50 U/ml penicillin, and 50 U/ml streptomycin (Lonza, Verviers, Belgium). The culture feeder layer cells while still maintaining a satisfactory amplification factor (7) . medium was accepted by the Dutch Central Committee on Research Involving Human Subjects (CCMO) as Other drawbacks with regard to the original Rheinwald and Green method include the use of high concensuitable for culturing epidermal cells for use in human clinical studies. trations of bovine serum in the culture medium, which results in noncompliance with current regulatory reAfter approximately 10-14 days of culture in which the cultures were passaged twice, epidermal cells (keraquirements; the extreme fragility of the sheets, which makes transport logistics and application onto the wound tinocytes and melanocyte coculture) were seeded at a density of 50,000 cells/cm 2 onto Matriderm, a 10 × 15 surface very difficult, and importantly the enzymatic (dispase) digestion required to remove the sheets from cm collagen-elastin matrix (dr. Suwelack Skin & Health Care, Billerbeck, Germany), which has the registration the tissue culture plastic, which results in poor and highly variable take, and frequent blistering of the sheets as a medical device. Epidermal cell-loaded Matriderm (EC-Matriderm) was further cultured at 37°C and 7.5% after application (2, 3, 6, 8, 13, 14) . In this study, we have taken all of these previous drawbacks into account and CO 2 for 3-5 days. For quality control, 3-mm-diameter biopsies were taken from the EC-Matriderm for analyses have developed a means to amplify large numbers of proliferating epidermal cells (EC) (keratinocytes and by MTT assay (at least three biopsies were taken from each of six independent donor experiments) and for (immelanocytes) and a means to easily transport and finally transfer the cells onto a dermal matrix, all in accordance muno)histological analysis. From three of these experiments, 1-cm 2 biopsies were also taken from each ECwith the regulations set by the Dutch Central Committee on Research Involving Human Subjects (CCMO). This Matriderm in order to determine the transferability and regenerative potential of the epidermal cells (three difin vitro study shows that a three-dimensional (3D) matrix composed of elastin and collagen types I, III, and V ferent donors, in duplicate). A schematic diagram of the protocol is shown in Figure 1 and humidity) for 24 h. After 24 h, the EC-Matriderm received fresh keratinocyte culture medium and was Human adult skin was obtained from healthy donors (with informed consent) undergoing abdominal dermolitransferred to the culture incubator for a further 48 h in order to determine whether the 24-h transport condition pectomy and was used directly after surgery. The VU University Medical Center approved of the experiments had long-lasting detrimental effects on cell metabolism and survival. Biopsies (10 × 3 mm diameter) were taken described in this article.
From 3 cm 2 full-thickness skin, epidermal sheets from different areas of the EC-Matriderm at time 0 (control), after 24 h at ambient condition, and after 48-h rewere separated from dermis by incubation in Dispase II (Roche, Mannheim, Germany) overnight at 4°C. Keraplacement in the culture incubator. Biopsies were analyzed by MTT assay to determine metabolic activity and tinocytes and melanocytes were isolated from the epidermis by incubating for 10 min in trypsin 0.125% cell survival. The values of the 10 biopsies obtained per (Table 1 ). An average of 2.9 × 10 6 (±0.4 × 10 6 ) epidermal cells was isolated from each 1 reagent (Roche, Penzberg, Germany). After incubation for 2 h at 37°C the biopsies were transferred to a 96-well cm 2 of skin. After 8-9 days, cultures had reached 80-90% confluency and had amplified by a factor 1.6 ± 0.3. microtiter plate containing 200 µl per well isopropanol, acidified with 0.04 M HCL (3:1) and incubated overThese subconfluent cultures were then passaged. After a total culture period of 10-14 days, the amplification facnight at room temperature. Extractant solution (100 µl) was then transferred to a 96-well microtiter plate for optor was 5.4 ± 0.7 compared to the original cell number obtained from a 1 cm 2 skin biopsy. These passage 2 kertical density (OD) measurements at 550 nm and a reference wavelength of 650 nm. An absorbance above 0.05 atinocytes were seeded at a density of 50,000 keratinocytes/cm 2 and whether the cells are distributed evenly throughout Aurora, USA), and cytokeratin (LP34, IgG1 Dako, Glosthe carrier. Therefore, epidermal cells were cultured in trup, Denmark). For detection of Ki67, keratin 6, keratin Matriderm for 3-5 days. Hereafter, multiple 3-mm biop-10, and cytokeratin a standard method for antigen resies were taken from different regions of EC-Matriderm trieval on paraffin sections was performed. Sections and metabolic activity/cell viability was determined with were immersed in 0.01 M sodium citrate buffer (pH 6.0) the aid of an MTT assay. In total six independent donor for 30 min at 100°C followed by slowly cooling to room experiments were performed in which 3-12 punch bioptemperature and washing in PBS. For keratin 10 and sies were analyzed from each 150-cm 2 area of ECcytokeratin only, an additional protease digestion step Matriderm. All biopsies contained viable cells. The inwith 4 mg/ml pepsin in 0.2 M HCl was performed for terdonor and intradonor variability was very low (mean 15 min at room temperature. Immunohistochemical OD 0.21 ± 0.01 and 0.23 ± 0.03, respectively), indicatanalysis of melanoma-associated antigen (NKI/beteb, ing that the protocol was highly reproducible and robust IgG2b, Monosan, Uden, The Netherlands) was per- (Fig. 2) . formed using 5-µm frozen sections that were air-dried In order to determine the distribution of epidermal and fixed in acetone for 10 min prior to incubation with keratinocytes within the EC-Matriderm, 3-mm biopsies the primary antibody. After fixation and antigen rewere taken for immunohistochemical staining with antitrieval, sections were washed in PBS, incubated with cytokeratin. Individual keratinocytes were distributed primary antibody for 1 h at room temperature followed evenly over the seeding surface of the carrier (Fig. 3b) . by incubation with avidin-biotin-peroxidase complex Penetration into the carrier was limited and no keratino-(Envision+ System, Dako). All sections were washed in cytes were observed on the lower surface of the carrier. PBS and were counterstained with hematoxylin.
Notably, no differentiating keratinocyte clones were observed, indicating that the Matriderm carrier is enriched Statistical Analysis with proliferating, undifferentiating keratinocytes. All data are presented as mean ± SEM. The number of experiments that represent different donors with interTransport Conditions for EC-Matriderm nal duplicates is stated in the figure legends. Statistical
When considering a future clinical application for calculations were performed as follows: two-way ANOVA EC-Matriderm it is important to predefine the transport with Bonferroni posttest was performed using GraphPad conditions. Therefore, we determined whether ECPrism version 4.00 for Windows (GraphPad Software, Matriderm could remain outside of the culture incubator San Diego, CA, USA, www.graphpad.com). Differences for a period of 24 h without any long-term adverse efwere significant when *p < 0.05, **p < 0.01, and ***p < fects occurring with regards to EC metabolic activity 0.005 relative to control. and viability (Fig. 4) . When EC-Matriderm was placed RESULTS under transport conditions (HBSS, 20°C, atmospheric Epidermal Cell Amplification oxygen and humidity) for 24 h, a slight decrease in metabolic activity was observed compared to parallel con-A coculture of keratinocytes and melanocytes was expanded from 1 cm 2 of healthy skin derived from six trol cultures. However when EC-Matriderm was trans- ferred from transport conditions back to optimum duplicates) (Fig. 3d) . Histological analysis showed that the reconstructed epidermis was fully differentiated and culture conditions again a full recovery was observed, indicating no long-lasting negative effects due to the contained a compact basal layer of cells, a stratum spinosum, stratum granulosum, and stratum corneum transport conditions. Indeed, the metabolic activity was greater than at the beginning of the experiment, indicat- (Fig. 5) . Melanocytes (NKI-beteb staining) and proliferating cells (Ki67 staining) were located throughout the ing that the cultures were actively growing again after transport.
basal layer at a similar frequency to that found in native skin.
Epidermal differentiation was normal as shown by Transfer of Epidermal Cells From EC-Matriderm keratin 10 immunostaining. Only keratin 6 immunoto Dermis Results in Epidermal Regeneration
staining was clearly different in that it was expressed suprabasally in the regenerated epidermis whereas it was Next the cell-seeded surface of EC-Matriderm was placed in contact with human dermis and cultured for 3 absent in native epidermis. days air exposed (Fig. 3c) . Hereafter, the EC-Matriderm DISCUSSION was removed and it was determined whether epidermal cell transfer had occurred to such a degree that the epiThis study describes a potential novel cell culture, transport, and transfer protocol that may be suitable for dermis could be regenerated. Indeed, epidermis regenerated with a 100% success rate with no epidermal blisterdelivering cultured proliferating EC to large open skin wounds. In this in vitro study, we have taken into acing: no separation of the epidermis from the basement membrane (three independent donors each with internal count the amplification factor of the cultured EC, the composition of the culture medium with respect to regulatory issues, the type of transport carrier used, and the success rate of epidermal regeneration after transfer to human dermis. This study included a slight refinement of the culture medium [compared to our previous study (7)] in order for the EC-Matriderm to comply with the regulations set by the Dutch Central Committee on Research Involving Human Subjects (CCMO) as suitable for human clinical studies, our future aim. Therefore, we first confirmed that the amplification factor of the cultured EC was still in the same order of magnitude as our previous study. Indeed, enough EC could be cultured from 1 cm 2 of skin to produce 319 ± 79 cm 2 EC-Matriderm, which correlated closely to our previously reported 400-fold amplification factor. This amplification factor is somewhat less than that reported by the Rheinwald and Green method (ϳ600-fold). This is most likely to be due to the absence of 3T3 feeder cells in our method. However, it should also be noted that it takes 3-4 weeks of culture to obtain this amplification factor and a confluent sheet suitable for transplantation compared to the 2-week culture protocol described in this study (12). Our shortened culture protocol is extremely beneficial when considering treating burns patients with autologous EC.
In our study we chose Matriderm as a transport carrier for the EC. This 3D matrix is registered as a medical device and has previously been used in clinical studies for stimulating dermal regeneration in severe burns (15,26). Here we describe a potentially novel application for this commercially available artificial matrix. Seeding EC onto Matriderm makes it possible to transport and transfer keratinocytes as single proliferating, undifferentiated cells with good regenerative potential. This is favorable above transporting and transferring differentiated keratinocytes, which have low regenerative potential. Our method was reproducible and showed little inter-and intraexperimental variation with regards to location and number of viable cells within the Matriderm. Other investigators have also realized the potential of transporting single proliferating keratinocytes to the wound rather than confluent differentiated EC cultures.
A number of strategies have been used for delivering subconfluent keratinocytes onto a wound bed. One of these is to spray a suspension of epidermal cells onto the wound with the aid of a nozzle cell spray apparatus (19). Although this is a very attractive technique, it does nique is applied in a one-step protocol, without EC amtute and to transplant this entire construct containing living cells (keratinocytes and fibroblasts) and the dermal plification. The skin is excised and epidermal cells are isolated and then sprayed directly onto the wound, all matrix onto the wound bed. In contrast to transport carrier systems, the dermal matrix is incorporated into the within the time allotted to surgery. Obviously this demands time and expertise unrelated to patient care from wound bed rather than being discarded after autologous cell transfer. A number of clinical studies have been declinicians. A further drawback with spraying keratinocytes in suspension onto the wound bed is the risk of an scribed in which autologous skin substitutes have been used to treat deep burns (4, 18) and chronic ulcers uneven delivery, particularly if the wound bed is not entirely horizontal. The use of EC-Matriderm potentially (10, 27) . Matriderm has been used as a dermal matrix in a preclinical study for the in vitro construction of a skin overcomes both of these problems because the single proliferating keratinocytes do not undergo rapid terminal substitute (11). Whereas these studies look promising, the logistics around amplifying both autologous cell differentiation due to their cell-substratum contacts, and furthermore the EC-Matriderm is designed to be applied types (keratinocytes and fibroblasts) in a limited time period in order to construct enough skin substitutes to as a living dressing onto the wound bed.
Other investigators have treated burns with cultured cover large wounds, as well as the transport conditions still remain important issues. autologous keratinocytes suspended in fibrin glue (17). Again a drawback with this method lies with the possiIn this study we were able to show that EC within the EC-Matriderm were transferred to human dermis bility of uneven delivery. A limited number of transport carrier systems have been described (6) . Polyurethane within 3 days to such an extent that fully differentiated human epidermis regenerated within 2 weeks. This 3-wound dressings and the dermal regeneration template Integra TM have been used to transfer keratinocytes to day transfer period was decided after considering the logistics of a future clinical application and would correathymic mice (29) and pigs (16,25). The eventual implementation of these carrier systems, together with our spond with the time between applying the EC-Matriderm to a patient and the first dressing change after transproposed carrier, will depend on future studies describing the clinical outcome of multicenter trials and the plantation. The regenerated epidermis showed no signs of blistering (no separation of the epidermis from the costs of the transport carrier.
An alternative method to transplant keratinocytes basement membrane) and contained a compact basal layer of cells, stratum spinosum, stratum granulosum, onto a wound bed is to construct in vitro a skin substi- 
